Being dealt the 12th pick in a fantasy draft can make managers feel like a vulture. They aren’t there to grab the top talent; they’re left to pick around at what’s left after the rest of the league ...

Strategy shifts from passive bitcoin accumulation to actively managing balance sheet to boost bitcoin per share value. "Our ability to sell bitcoin either to buy U.S. dollars or sell bitcoin to buy ...

The Maharashtra State Board has announced the HSC Result 2026 with an overall pass percentage of 89.79 per cent. While most students have cleared the exam, many have not. As per the data shared by the ...

Key Information: The Maharashtra State Board of Secondary and Higher Secondary Education (MSBSHSE) is set to announce the results for the Class 12th (Higher Secondary) Examination 2026 on May 2, 2026, ...

Designed to overcome limitations of single-cytokine strategies, representing a potentially best-in-class breakthrough for the treatment of cancer PHILADELPHIA & SAN FRANCISCO--(BUSINESS ...

SEND is a novel synthetic cytokine receptor designed to enable simultaneous activation of multiple T cell signaling pathways to enhance T cell efficacy and durability SEND demonstrates strong ...

Among the new projects the company secured last year were six late-stage programs, the company said. Roughly two-thirds of WuXi Biologics’ 2025 signings were focused on bispecifics and antibody-drug ...

Today, the Council approved conclusions on the new EU’s bioeconomy strategy. The Council conclusions welcome the vision for a competitive and sustainable bioeconomy by 2040, promote the use of ...

A biologist takes inspiration from fungus-growing ants in his research with microbes that grow on roots in soil. Leafcutter ants, seen here on fungi, inspired Ulrich Mueller’s research on microbiome ...

Hello, and welcome to Nuvation Bio's Fourth Quarter and Full Year 2025 Financial Results and Corporate Update Call. Today's call is being recorded, and a replay will be available. [Operator ...

After 2024 marked the return of the biotech megaround, 2025 proved it wasn’t just a one-year anomaly. Last year was characterized by fewer but larger venture capital financings for biotech, with ...